Related Experiment Videos
Perichiasmal tumors: diagnostic and prognostic features.
Neurosurgery
|September 1, 1984
Summary
Tumors compressing the optic pathways often cause visual loss, typically in one eye. Most patients experienced visual field defects or relative afferent pupillary defects (RAPD), with many achieving good vision post-surgery.
Area of Science:
- Neuro-ophthalmology
- Neurology
- Oncology
Background:
- Intracranial tumors can compress critical visual pathways, including the optic nerve, optic chiasm, and optic tract.
- Such compression frequently leads to significant visual impairment, necessitating a thorough understanding of associated visual field defects.
Purpose of the Study:
- To analyze the clinical presentation and visual outcomes in patients with tumors compressing the intracranial visual pathways.
- To characterize the patterns of visual field defects and pupillary responses in this patient cohort.
Main Methods:
- Retrospective review of 49 patients with tumors compressing the intracranial optic nerve, optic chiasm, or optic tract.
- Analysis of presenting symptoms, visual acuity, pupillary examination findings (relative afferent pupillary defect - RAPD), and visual field testing results.
Main Results:
- The majority of patients presented with visual loss predominantly affecting one eye.
- Seventy-seven percent had a relative afferent pupillary defect (RAPD), and 96% exhibited a hemianopic defect; all patients had at least one of these findings.
- Junctional visual field defects (39%) were nearly as common as bitemporal defects (46%), with hemianopic defects often obscuring nerve fiber bundle defects.
- Poor preoperative acuity correlated with poorer postoperative acuity, though 95% achieved 20/40 or better in at least one eye postoperatively.
Conclusions:
- Compression of intracranial visual pathways by tumors characteristically causes unilateral visual loss and specific visual field or pupillary defects.
- While visual field patterns can be complex, surgical outcomes are often favorable, with most patients retaining functional vision.